Development of an osteoconductive PCL-PDIPF-hydroxyapatite composite scaffold for bone tissue engineering

Journal of Tissue Engineering and Regenerative Medicine

Volumn 5, Issue 6, 2011, Pages

  Fernandez, Juan Manuel ^a   Molinuevo, M Silvina ^a   Cortizo, M Susana ^a   Cortizo, Ana M ^a  

^a FACULTAD DE CIENCIAS EXACTAS   (Argentina)

Author keywords

Biocompatibility; Bone tissue engineering; Hydroxyapatite; Osteoblasts; Poly caprolactone; Polydialkyl fumarates

Indexed keywords

BIOCOMPATIBILITY; BIOMECHANICS; BONE; CELL CULTURE; OSTEOBLASTS; POLYMER FILMS; SCAFFOLDS (BIOLOGY);

BONE TISSUE ENGINEERING; CELL LINES; COMPOSITE SCAFFOLDS; FUMARATES; HYDROXYAPATITE COMPOSITE; MECHANICAL; OSTEOCONDUCTIVE; PHYSICO-CHEMICALS; POLY(Ε CAPROLACTONE); POLYDIALKYL FUMARATE;

HYDROXYAPATITE;

COLLAGEN TYPE 1; FUMARIC ACID DERIVATIVE; HYDROXYAPATITE; POLYCAPROLACTONE; POLYDIISOPROPYL FUMARATE; TRANSCRIPTION FACTOR RUNX2; UNCLASSIFIED DRUG;

ARTICLE; BIOCOMPATIBILITY; CELL PROLIFERATION; CLINICAL EVALUATION; CONTROLLED STUDY; DISPERSION; EVIDENCE BASED PRACTICE; HUMAN; HUMAN CELL; HUMAN TISSUE; INTERPHASE; MECHANICS; NONHUMAN; OSTEOBLAST; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; YOUNG MODULUS;

EID: 79956257420     PISSN: 19326254     EISSN: 19327005     Source Type: Journal    
DOI: 10.1002/term.394     Document Type: Article

References (28)

1. Bradford MM. 1976; A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254.
2. Choi D, Marra KG, Kumta PN. 2004; Chemical synthesis of hydroxyapatite/poly(ε-caprolactone) composites. Mat Res Bull 39: 417-432.
3. Cortizo AM, Molinuevo MS, Barrio DA, et al. 2006; Osteogenic activity of vanadyl(IV)-ascorbate complex: evaluation of its mechanisms of action. Int J Biochem Cell Biol 38: 1171-1180.
4. Cortizo MS. 2007; Polymerization of diisopropyl fumarate under microwave irradiation. J Appl Polym Sci 103: 3785-3791.
5. Cortizo MS, Molinuevo MS, Cortizo AM. 2008; Biocompatibility and biodegradation of polyester and polyfumarate based-scaffolds for bone tissue engineering. J Tissue Eng Regen Med 2: 33-42.
6. Ding WG, Jiang SD, Zhang YH, et al. 2010; Bone loss and impaired fracture healing in spinal cord injured mice. Osteoporos Int (DOI: 10.1007/s00198-010-1256-8).
7. Fernandez JM, Molinuelo MS, Cortizo AM, et al. 2010; Characterization of poly-ε-caprolactone/polyfumarate blends as scaffolds for bone tissue engineering. J Biomat Sci Polym Ed 21: 1297-1312.
8. Habibovic P, de Groot K, 2007; Osteoinductive biomaterials-properties and relevance in bone repair. J Tissue Eng Regen Med 1: 25-32.
9. Joschek S, Nies B, Krotz R, et al. 2000; Chemical and physicochemical characterization of porous hydroxyapatite ceramics made of natural bone. Biomaterials 21: 1645-1658.
10. Kim HW, Knowles JC, Kim HE. 2004; Hydroxyapatite/poly(ε-caprolactone) composite coatings on hydroxyapatite porous bone scaffold for drug delivery. Biomaterials 25: 1279-1287.
11. Kim SS, Park MSA, Jeon O, et al. 2006; Poly(lactide-co-glycolide)/hydroxyapatite composite scaffolds for bone tissue engineering. Biomaterials 27: 1399-1409.
12. Kuhn LT, Grynpas MD, Rey CC, et al. 2008; A comparison of the physical and chemical differences between cancellous and cortical bovine bone mineral at two ages. Calcif Tissue Int 83: 146-154.
13. Laemmli UK. 1970; Cleavage of structural protein during the assembly of the head of bacteriophage T4. Nature 227: 680-685.
14. Li J, Dou Y, Yang J, et al. 2009; Surface characterization and biocompatibility of micro- and nano-hydroxyapatite/chitosan-gelatin network films. Mat Sci Eng C-Bio S 29: 1207-1215.
15. Mano JF, Silva GA, Azevedo HS, et al. 2007; Natural origin biodegradable systems in tissue engineering and regenerative medicine: present status and some moving trends. J R Soc Interface 4: 999-1030.
16. McCarthy AD, Etcheverry SB, Bruzzone L, et al. 1997; Effects of advanced glycation end-products on the proliferation and differentiation of osteoblast-like cells. Mol Cell Biochem 170: 43-51.
17. Molinuevo MS, Schurman L, McCarthy AD, et al. 2010; C. Effect of Metformin on bone marrow progenitor cell differentiation: in vivo and in vitro studies. J Bone Miner Res 25: 211-221.
18. Ooi CY, Uamdi MH, Ramesh S. 2007; Properties of hydroxyapatite produced by annealing of bovine bone. Ceram Int 33: 1171-1177.
19. Partridge NC, Alcorn D, Michelangeli VP, et al. 1983; Morphological and biochemical characterization of four clonal osteogenic sarcoma cell lines of rat origin. Cancer Res 43: 4308-4314.
20. Prabhakaran MP, Venugopal J, Ramakrishna S. 2009; Electrospun nanostructured scaffols for bone tissue engineering. Acta Biomater 5: 2884-2893.
21. Quarles LD, Yahay DA, Lever LW, et al. 1992; Distinct proliferative and differentiated stages of murine MC3T3E1 cells in culture: an in vitro model of osteoblast development. J Bone Miner Res 7: 683-692.
22. Salgado AJ, Coutinho OP, Reis RL. 2004; Bone tissue engineering: state of the art and future trends. Macromol Biosci 4: 743-765.
23. Scaglione S, Ilengo C, Fato M, et al. 2009; Hydroxyapatite-coated polycaprolactone wide mesh as a model of open structure for bone regeneration. Tissue Eng Part A 15: 155-163.
24. Šupová M. 2009; Problem of hydroxyapatite dispersion in polymer matrices: a review. J Mater Sci: Mater Med 20: 1201-1213.
25. Tullberg-Reinert H, Jundt G. 1999; In situ measurement of collagen synthesis by human bone cells with a Sirius red-based colorimetric microassay: effects of transforming growth factor β2 and ascorbic acid 2-phosphate. Histochem Cell Biol 112: 271-276.
26. Walters MA, Leung YC, Blumenthal NC, et al. 1990; A Raman and infrared spectroscopic investigation of biological hydroxyapatite. J Inorg Biochem 39: 193-200.
27. Wang M. 2003; Developing bioactive composite materials for tissue replacement. Biomaterials 24: 2133-2151.
28. Webster TJ, Ergun C, Doremus RH, et al. 2000; Specific proteins mediate enhanced osteoblast adhesion on nanophase ceramics. J Biomed Mater Res 51: 475-483.